Eledon Pharmaceuticals, Inc.ELDNNASDAQ
Loading
Debt to Equity Over TimeCompressed
Percentile Rank54
3Y CAGR-19.1%
5Y CAGR+44.1%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
-19.1%/yr
Annual compound
5Y CAGR
+44.1%/yr
Recent deceleration
Percentile
P54
Within normal range
vs 5Y Ago
6.2x
Strong expansion
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.00 | -42.0% |
| 2024 | 0.01 | -84.8% |
| 2023 | 0.05 | +499.6% |
| 2022 | 0.01 | +89.0% |
| 2021 | 0.00 | +520.7% |
| 2020 | 0.00 | -97.8% |
| 2019 | 0.03 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | -100.0% |
| 2016 | 0.13 | - |